Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 05 Mar 2025 – 20 Aug 2026, limited by ITI Bharat Consumption Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | ITI Bharat Consumption Fund | Nifty 500 |
|---|---|---|
| 05 Mar 2025 | ₹100.00 | ₹100.00 |
| 18 Apr 2025 | ₹108.32 | ₹107.04 |
| 02 Jun 2025 | ₹110.42 | ₹112.73 |
| 16 Jul 2025 | ₹114.71 | ₹115.88 |
| 30 Aug 2025 | ₹114.72 | ₹110.89 |
| 13 Oct 2025 | ₹116.55 | ₹115.00 |
| 27 Nov 2025 | ₹117.19 | ₹118.22 |
| 10 Jan 2026 | ₹113.76 | ₹115.85 |
| 23 Feb 2026 | ₹111.98 | ₹115.94 |
| 09 Apr 2026 | ₹105.36 | ₹108.79 |
| 23 May 2026 | ₹108.91 | ₹111.82 |
| 07 Jul 2026 | ₹115.79 | ₹115.36 |
| 20 Aug 2026 | ₹120.10 | ₹116.08 |
| Metric | ITI · Regular NAV ₹11.93 Very High risk ★★☆☆☆ 1Y | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| +2.54% | +5.83% | |
| — | +15.63% | |
| — | +13.23% | |
| — | +13.85% | |
| +13.37% | +12.26% | |
| +9.78% | — | |
| — | +15.60% | |
| — | +14.52% | |
| — | +13.74% | |
| Risk | ||
| 13.71% | 15.62% | |
| -0.29 | 0.43 | |
| -0.41 | 0.59 | |
| -17.06% | -23.65% | |
| Nifty 500 | — | |
| — | +3.42% | |
| — | 0.95 | |
| — | 105.9% | |
| — | 93.6% | |
| 2.57% | 2.39% | |
| ₹345.15Cr | ₹1,161Cr | |
| 0.50% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 79% | 45% | |
| Rajesh Bhatia | — | |
| 05 Mar 2025 | — | |
| 54 | — | |
| 40.4% | — | |
| 1.4% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.